Real-World Immunosuppressant Treatment Patterns for Patients with Lupus Nephritis in the United States

被引：0
|
作者：
Jacob N. Hunnicutt
Mary Elizabeth Georgiou
Liyuan Ma
Roger A. Levy
Kerry Gairy
机构：
[1] GSK,
[2] Value Evidence and Outcomes,undefined
[3] GSK,undefined
[4] Value Evidence and Outcomes,undefined
[5] GSK,undefined
[6] Value Evidence and Outcomes,undefined
[7] GSK,undefined
[8] Global Medical Affairs,undefined
来源：
Rheumatology and Therapy | 2023年 / 10卷
关键词：
Corticosteroids; Induction treatment; Lupus nephritis; Maintenance treatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1305 / 1318
页数：13
相关论文
共 50 条
  • [21] Clinicopathological Patterns and Outcomes in Patients with Lupus Nephritis and Hyperuricemia
    Wen, Qiong
    Tang, Xueqing
    Zhou, Qian
    Chen, Wei
    Yu, Xueqing
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (11)
  • [22] Renal response and its predictive factors of lupus nephritis: a 2-year real-world study of 56 hospital-based patients
    Keqian Du
    Xuecheng Zhang
    Junmei Feng
    Sijie Zhong
    Jun Qi
    Zhiming Lin
    Clinical Rheumatology, 2022, 41 : 3363 - 3371
  • [23] Cyclosporine for the treatment of lupus nephritis in patients with systemic lupus erythematosus
    Yang, Tzu-Han
    Wu, Tsai-Hung
    Chang, Yuh-Lih
    Liao, Hsien-Tzung
    Hsu, Chia-Chen
    Tsai, Chang-Youh
    Chou, Yueh-Ching
    CLINICAL NEPHROLOGY, 2018, 89 (04) : 277 - 285
  • [24] Renal response and its predictive factors of lupus nephritis: a 2-year real-world study of 56 hospital-based patients
    Du, Keqian
    Zhang, Xuecheng
    Feng, Junmei
    Zhong, Sijie
    Qi, Jun
    Lin, Zhiming
    CLINICAL RHEUMATOLOGY, 2022, 41 (11) : 3363 - 3371
  • [25] Population pharmacokinetics model and initial dose optimization of tacrolimus in children and adolescents with lupus nephritis based on real-world data
    Chen, Xiao
    Wang, Dong-Dong
    Xu, Hong
    Li, Zhi-Ping
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 20 (02) : 1423 - 1430
  • [26] Real-world data in lupus nephritis: results from a European survey on renal function testing and burden of disease progression
    Pesce, Francesco
    Fernandes, Ancilla
    Clamp, David
    Asin, Beatriz
    Goddard, Emily
    Gillespie-Akar, Liane
    Eberhardt, Alice
    CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 (12) : 2215 - 2222
  • [27] Real-world treatment and outcome patterns of patients with mantle cell lymphoma in China: A large, multicenter retrospective analysis
    Yang, Ping
    Cai, Qing-qing
    Zhang, Wei
    Liu, Shuo-zi
    Liu, Hui
    Sun, Xiu-hua
    Dong, Yu-jun
    Xiao, Xiu-bin
    Wang, Jing-wen
    Li, Zhen-ling
    Huang, Wen-rong
    Li, Li-hong
    Bao, Hui-zheng
    Yang, Wei
    Wang, Ya-lan
    Wang, Shu-ye
    He, Juan
    Li, Xiao-ling
    Liu, Ai-chun
    Jing, Hong-mei
    CANCER MEDICINE, 2023, 12 (12): : 13204 - 13216
  • [28] Real world data on dual BLyS/APRIL inhibition with telitacicept for lupus nephritis
    Jin, Jingjing
    Tan, Meng
    Tan, Ying
    Zhao, Minghui
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2025,
  • [29] Prognostic factors for treatment response in patients with lupus nephritis
    Miranda-Hernandez, Dafhne
    Cruz-Reyes, Claudia
    Angeles, Ulises
    Javier Jara, Luis
    Angel Saavedra, Miguel
    REUMATOLOGIA CLINICA, 2014, 10 (03): : 164 - 169
  • [30] Longterm Data on Sirolimus Treatment in Patients with Lupus Nephritis
    Yap, Desmond Y. H.
    Tang, Colin
    Chan, Gary C. W.
    Kwan, Lorraine P. Y.
    Ma, Maggie K. M.
    Mok, Maggie M. Y.
    Chan, Tak Mao
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (12) : 1663 - 1670
12345